Topoisomerase IV catalysis and the mechanism of quinolone action

被引:62
作者
Anderson, VE
Gootz, TD
Osheroff, N
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med Oncol, Nashville, TN 37232 USA
[3] Pfizer Inc, Pfizer Cent Res, Dept Canc Immunol & Infect Dis, Groton, CT 06340 USA
关键词
D O I
10.1074/jbc.273.28.17879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerase IV is.bacterial type II topoisomerase that is essential for proper chromosome segregation and is a target for quinolone-based antimicrobial agents. Despite the importance of this enzyme to the survival of prokaryotic cells and to the treatment of bacterial infections, relatively little is known about the details of its catalytic mechanism or the basis by which quinolones alter its enzymatic functions. Therefore, a series of experiments that analyzed individual steps of the topoisomerase IV catalytic cycle were undertaken to address these critical mechanistic issues. The following conclusions were drawn, First, equilibrium levels of DNA cleavage mediated by the bacterial enzyme were considerably (>10-fold) higher than those observed with its eukaryotic counterparts. To a large extent, this reflected decreased rates of DNA religation. Second, the preference of topoisomerase TV for catalyzing DNA decatenation over relaxation reflects increased rates of strand passage and enzyme recycling rather than a heightened recognition of intermolecular DNA helices, Third, quinolones stimulate topoisomerase IV-mediated DNA cleavage both by increasing rates of DNA scission and by inhibiting religation of cleaved DNA. Finally, quinolones inhibit the overall catalytic activity of topoisomerase TV primarily by interfering with enzyme-ATP interactions.
引用
收藏
页码:17879 / 17885
页数:7
相关论文
共 70 条
  • [1] THE ROLE OF TOPOISOMERASE-IV IN PARTITIONING BACTERIAL REPLICONS AND THE STRUCTURE OF CATENATED INTERMEDIATES IN DNA-REPLICATION
    ADAMS, DE
    SHEKHTMAN, EM
    ZECHIEDRICH, EL
    SCHMID, MB
    COZZARELLI, NR
    [J]. CELL, 1992, 71 (02) : 277 - 288
  • [2] USE OF INVITRO TOPOISOMERASE-II ASSAYS FOR STUDYING QUINOLONE ANTIBACTERIAL AGENTS
    BARRETT, JF
    GOOTZ, TD
    MCGUIRK, PR
    FARRELL, CA
    SOKOLOWSKI, SA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) : 1697 - 1703
  • [3] Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases
    Blanche, F
    Cameron, B
    Bernard, FX
    Maton, L
    Manse, B
    Ferrero, L
    Ratet, N
    Lecoq, C
    Goniot, A
    Bisch, D
    Crouzet, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2714 - 2720
  • [4] CORBETT AH, 1991, J BIOL CHEM, V266, P19666
  • [5] CORBETT AH, 1993, J BIOL CHEM, V268, P14394
  • [6] A PYRIMIDO[1,6-ALPHA]BENZIMIDAZOLE THAT ENHANCES DNA CLEAVAGE MEDIATED BY EUKARYOTIC TOPOISOMERASE II - A NOVEL CLASS OF TOPOISOMERASE II-TARGETED DRUGS WITH CYTOTOXIC POTENTIAL
    CORBETT, AH
    GUERRY, P
    PFLIEGER, P
    OSHEROFF, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) : 2599 - 2605
  • [7] WHEN GOOD ENZYMES GO BAD - CONVERSION OF TOPOISOMERASE-II TO A CELLULAR TOXIN BY ANTINEOPLASTIC DRUGS
    CORBETT, AH
    OSHEROFF, N
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) : 585 - 597
  • [8] DNA gyrase, topoisomerase IV, and the 4-quinolones
    Drlica, K
    Zhao, XL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) : 377 - +
  • [9] Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs
    Elsea, SH
    Westergaard, M
    Burden, DA
    Lomenick, JP
    Osheroff, N
    [J]. BIOCHEMISTRY, 1997, 36 (10) : 2919 - 2924
  • [10] DRUG FEATURES THAT CONTRIBUTE TO THE ACTIVITY OF QUINOLONES AGAINST MAMMALIAN TOPOISOMERASE-II AND CULTURED-CELLS - CORRELATION BETWEEN ENHANCEMENT OF ENZYME-MEDIATED DNA CLEAVAGE IN-VITRO AND CYTOTOXIC POTENTIAL
    ELSEA, SH
    MCGUIRK, PR
    GOOTZ, TD
    MOYNIHAN, M
    OSHEROFF, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2179 - 2186